Manulife (Manufacturers Life Insurance)’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $578K | Buy |
36,124
+900
| +3% | +$14.4K | ﹤0.01% | 2108 |
|
|
2025
Q1 | $602K | Sell |
35,224
-684
| -2% | -$11.7K | ﹤0.01% | 2051 |
|
|
2024
Q4 | $889K | Sell |
35,908
-772
| -2% | -$19.1K | ﹤0.01% | 1962 |
|
|
2024
Q3 | $1.05M | Sell |
36,680
-946
| -3% | -$27K | ﹤0.01% | 1902 |
|
|
2024
Q2 | $993K | Sell |
37,626
-39,877
| -51% | -$1.05M | ﹤0.01% | 1866 |
|
|
2024
Q1 | $2.5M | Buy |
77,503
+15,156
| +24% | +$490K | ﹤0.01% | 1441 |
|
|
2023
Q4 | $2.63M | Buy |
62,347
+730
| +1% | +$30.8K | ﹤0.01% | 1386 |
|
|
2023
Q3 | $2.37M | Buy |
61,617
+38,238
| +164% | +$1.47M | ﹤0.01% | 1386 |
|
|
2023
Q2 | $444K | Sell |
23,379
-27,246
| -54% | -$517K | ﹤0.01% | 2117 |
|
|
2023
Q1 | $785K | Buy |
50,625
+20,191
| +66% | +$313K | ﹤0.01% | 1750 |
|
|
2022
Q4 | $536K | Buy |
+30,434
| New | +$536K | ﹤0.01% | 1944 |
|
|
2022
Q2 | – | Sell |
-20,276
| Closed | -$112K | – | 3068 |
|
|
2022
Q1 | $112K | Sell |
20,276
-4,235
| -17% | -$23.3K | ﹤0.01% | 2945 |
|
|
2021
Q4 | $209 | Buy |
24,511
+87
| +0.4% | +$1 | ﹤0.01% | 2865 |
|
|
2021
Q3 | $212K | Buy |
24,424
+2,011
| +9% | +$17.5K | ﹤0.01% | 2941 |
|
|
2021
Q2 | $237K | Sell |
22,413
-266
| -1% | -$2.81K | ﹤0.01% | 2985 |
|
|
2021
Q1 | $364K | Buy |
22,679
+51
| +0.2% | +$819 | ﹤0.01% | 2484 |
|
|
2020
Q4 | $1.05M | Buy |
22,628
+3,511
| +18% | +$162K | ﹤0.01% | 1789 |
|
|
2020
Q3 | $673K | Buy |
19,117
+8,000
| +72% | +$282K | ﹤0.01% | 1847 |
|
|
2020
Q2 | $283K | Buy |
+11,117
| New | +$283K | ﹤0.01% | 2295 |
|